BNGO
Price
$5.36
Change
+$0.02 (+0.37%)
Updated
Feb 21 closing price
Capitalization
57.43M
GH
Price
$42.87
Change
-$4.53 (-9.56%)
Updated
Feb 21 closing price
Capitalization
2.46B
74 days until earnings call
Ad is loading...

BNGO vs GH

Header iconBNGO vs GH Comparison
Open Charts BNGO vs GHBanner chart's image
Bionano Genomics
Price$5.36
Change+$0.02 (+0.37%)
Volume$78.89K
Capitalization57.43M
Guardant Health
Price$42.87
Change-$4.53 (-9.56%)
Volume$5.74M
Capitalization2.46B
BNGO vs GH Comparison Chart
Loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNGO vs. GH commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and GH is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (BNGO: $5.34 vs. GH: $47.40)
Brand notoriety: BNGO: Not notable vs. GH: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 41% vs. GH: 131%
Market capitalization -- BNGO: $57.43M vs. GH: $2.46B
BNGO [@Medical Specialties] is valued at $57.43M. GH’s [@Medical Specialties] market capitalization is $2.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileGH’s FA Score has 0 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • GH’s FA Score: 0 green, 5 red.
According to our system of comparison, GH is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 4 TA indicator(s) are bullish while GH’s TA Score has 3 bullish TA indicator(s).

  • BNGO’s TA Score: 4 bullish, 4 bearish.
  • GH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than GH.

Price Growth

BNGO (@Medical Specialties) experienced а -3.44% price change this week, while GH (@Medical Specialties) price change was +0.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.70%. For the same industry, the average monthly price growth was -1.38%, and the average quarterly price growth was +2.36%.

Reported Earning Dates

BNGO is expected to report earnings on Nov 09, 2023.

GH is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Medical Specialties (-1.70% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than BNGO($57.4M). GH YTD gains are higher at: 55.155 vs. BNGO (-69.140). BNGO has higher annual earnings (EBITDA): -213.4M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. BNGO (102M). BNGO has less debt than GH: BNGO (79.4M) vs GH (1.35B). GH has higher revenues than BNGO: GH (564M) vs BNGO (36.1M).
BNGOGHBNGO / GH
Capitalization57.4M2.47B2%
EBITDA-213.4M-433.3M49%
Gain YTD-69.14055.155-125%
P/E RatioN/AN/A-
Revenue36.1M564M6%
Total Cash102M1.17B9%
Total Debt79.4M1.35B6%
FUNDAMENTALS RATINGS
BNGO vs GH: Fundamental Ratings
BNGO
GH
OUTLOOK RATING
1..100
177
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9836
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for GH (66) in the Medical Or Nursing Services industry. This means that BNGO’s stock grew somewhat faster than GH’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that BNGO’s stock grew similarly to GH’s over the last 12 months.

BNGO's SMR Rating (98) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that BNGO’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for BNGO (98) in the Biotechnology industry. This means that GH’s stock grew somewhat faster than BNGO’s over the last 12 months.

BNGO's P/E Growth Rating (91) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that BNGO’s stock grew similarly to GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOGH
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUK113.161.37
+1.23%
Duke Energy Corp
BRBS3.62-0.08
-2.16%
Blue Ridge Bankshares
NFE12.05-0.30
-2.43%
New Fortress Energy
ESRT8.75-0.26
-2.89%
Empire State Realty Trust
PHAT5.54-0.22
-3.82%
Phathom Pharmaceuticals

BNGO and

Correlation & Price change

A.I.dvisor tells us that BNGO and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
-3.61%
QDEL - BNGO
31%
Poorly correlated
-2.05%
CZMWY - BNGO
31%
Poorly correlated
+0.79%
ICCM - BNGO
30%
Poorly correlated
-3.23%
ARAY - BNGO
29%
Poorly correlated
-4.00%
TWST - BNGO
29%
Poorly correlated
-6.04%
More

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-3.27%
VCYT - GH
49%
Loosely correlated
-2.52%
BLFS - GH
37%
Loosely correlated
-1.50%
TWST - GH
36%
Loosely correlated
-6.04%
NTRA - GH
35%
Loosely correlated
-2.56%
BNGO - GH
35%
Loosely correlated
-3.61%
More